The LeukoStrat® CDx FLT3 Mutation Assay is a PCR-based in vitro diagnostic test designed to detect internal tandem duplications (ITD) FLT3 mutations and tyrosine kinase domain (TKD) FLT3 mutations in genomic DNA extracted from mononuclear cells obtained from peripheral blood or bone marrow aspirates of patients diagnosed with acute myelogenous leukemia.
The LeukoStrat® CDx FLT3 Mutation Assay is used as an aid in the assessment of patients for whom midostaurin treatment is being considered.
|
